Zenotech Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 683231, "name": "Zenotech Lab.", "stock_name": "Zenotech Lab.", "full_name": "Zenotech Laboratories Ltd", "name_url": "stocks-analysis/zenotech-lab", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "44.81", "chg": 0.94, "chgp": "2.14%", "dir": 1, "prev_price": "43.87", "mcapval": "271.00 Cr", "mcap": "Micro Cap", "scripcode": 532039, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE486F01012", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "19.68 k", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Zenotech Laboratories Ltd Falls 3.72% Amid Mixed Financial Signals and Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-falls-372-amid-mixed-financial-signals-and-market-volatility-3813024", "imagepath": "", "date": "2026-01-31 16:03:39", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 27:</strong> Positive Q4 2025 financial turnaround announced</p>\n <p><strong>Jan 28:</strong> Stock falls to 52-week low of Rs.43.01</p>\n <p><strong>Jan 29:</strong> Sharp intraday volatility with heavy volume</p>\n <p><strong>Jan 30:</strong> Week closes at Rs.44.76 (+2.08% on day)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.46.49</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.44.76</div><div class=\"stat-change negat..." }, { "title": "Zenotech Laboratories Ltd Falls to 52-Week Low of Rs.43.01 Amidst Continued Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-falls-to-52-week-low-of-rs4301-amidst-continued-underperformance-3807110", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_priceRelatedfactors_3807110.png", "date": "2026-01-28 09:51:17", "description": "Zenotech Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.43.01 on 28 Jan 2026, marking a significant milestone in the stock’s recent performance amid broader market gains." }, { "title": "Zenotech Laboratories Ltd Falls to 52-Week Low of Rs.43.01", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-falls-to-52-week-low-of-rs4301-3807122", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_priceRelatedfactors_3807122.png", "date": "2026-01-28 09:51:14", "description": "Zenotech Laboratories Ltd’s shares declined to a fresh 52-week low of Rs.43.01 on 28 Jan 2026, marking a significant price level for the pharmaceutical and biotechnology company amid ongoing market pressures and company-specific factors." }, { "title": "Zenotech Laboratories Ltd Reports Positive Financial Turnaround in Q4 2025", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-reports-positive-financial-turnaround-in-q4-2025-3804849", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_fintrenddot_3804849.png", "date": "2026-01-27 08:00:19", "description": "Zenotech Laboratories Ltd has demonstrated a notable financial turnaround in the quarter ended December 2025, shifting from a negative to a positive growth trajectory. Key metrics such as profit before tax, net sales, and earnings per share have all reached their highest levels in recent quarters, signalling a potential stabilisation in the company’s performance within the Pharmaceuticals & Biotechnology sector." }, { "title": "Zenotech Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-3804164", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_mojoScore_3804164.png", "date": "2026-01-25 10:10:04", "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Are Zenotech Laboratories Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-zenotech-laboratories-ltd-latest-results-good-or-bad-3802439", "imagepath": "", "date": "2026-01-23 19:15:32", "description": "Zenotech Laboratories Ltd's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a revenue of ₹10.23 crores, reflecting a year-on-year growth of 16.91% and a quarter-on-quarter increase of 18.40%. This revenue growth indicates a positive trend in sales, marking the second-highest quarterly revenue in the company's recent history.\n\nHowever, the net profit for the same quarter was reported at a loss of ₹0.84 crores, which is a significant decline compared to the previous quarter and the same quarter last year. This loss can be attributed to an extraordinary tax charge that exceeded the profit before tax, raising concerns about the company's tax planning and potential prior period adjustments. The effective tax rate for the quarter was an unprecedented 165.87%, which has distorted the profitability metrics and overshadowed the revenue growth.\n\nThe oper..." }, { "title": "Zenotech Laboratories Q2 FY26: Tax Anomaly Triggers Loss Despite Revenue Growth", "link": "https://www.marketsmojo.com/news/result-analysis/zenotech-laboratories-q2-fy26-tax-anomaly-triggers-loss-despite-revenue-growth-3802400", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_quaterlyResult_3802400.png", "date": "2026-01-23 18:16:25", "description": "Zenotech Laboratories Limited, a micro-cap pharmaceutical company specialising in generic injectables for oncology and anaesthesiology, reported a net loss of ₹0.84 crores in Q2 FY26, a sharp reversal from the ₹0.99 crores profit posted in Q1 FY26. The unexpected loss came despite revenue growth of 18.40% quarter-on-quarter, primarily driven by an extraordinary tax charge of ₹2.09 crores representing a staggering 165.87% tax rate. The stock, currently trading at ₹46.50 with a market capitalisation of ₹276.00 crores, has declined 0.70% over the past week and remains in a bearish technical trend." }, { "title": "Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3783917", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_mojoScore_3783917.png", "date": "2026-01-07 08:16:41", "description": "Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators amid ongoing financial headwinds. While the company continues to face significant profitability pressures and valuation concerns, recent technical trend improvements have prompted a more cautious but less negative outlook from analysts." }, { "title": "Zenotech Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-3780483", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZenotechLaborat_mojoScore_3780483.png", "date": "2026-01-04 10:10:27", "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 July 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." } ], "total": 112, "sid": "683231", "stock_news_url": "https://www.marketsmojo.com/news/zenotech-laboratories-683231" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "24-Jan-2026", "details": "Copies of extracts of Standalone Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 published in newspapers today i.e. January 24 2026.", "source": "BSE" }, { "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025", "datetime": "23-Jan-2026", "details": "Unaudited Financial Results for the quarter and nine months ended December 31 2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On January 23 2026", "datetime": "23-Jan-2026", "details": "Outcome of the Board Meeting held today i.e. January 23 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17", "dt": "2017-06-01", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

Jan 27: Positive Q4 2025 financial turnaround announced

Jan 28: Stock falls to 52-week low of Rs.43.01

Jan 29: Sharp intraday volatility with heavy volume

Jan 30: Week closes at Rs.44.76 (+2.08% on day)

Read full news article

Zenotech Laboratories Ltd Falls to 52-Week Low of Rs.43.01 Amidst Continued Underperformance

2026-01-28 09:51:17

Zenotech Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.43.01 on 28 Jan 2026, marking a significant milestone in the stock’s recent performance amid broader market gains.

Read full news article

Zenotech Laboratories Ltd Falls to 52-Week Low of Rs.43.01

2026-01-28 09:51:14

Zenotech Laboratories Ltd’s shares declined to a fresh 52-week low of Rs.43.01 on 28 Jan 2026, marking a significant price level for the pharmaceutical and biotechnology company amid ongoing market pressures and company-specific factors.

Read full news article

Zenotech Laboratories Ltd Reports Positive Financial Turnaround in Q4 2025

2026-01-27 08:00:19

Zenotech Laboratories Ltd has demonstrated a notable financial turnaround in the quarter ended December 2025, shifting from a negative to a positive growth trajectory. Key metrics such as profit before tax, net sales, and earnings per share have all reached their highest levels in recent quarters, signalling a potential stabilisation in the company’s performance within the Pharmaceuticals & Biotechnology sector.

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-01-25 10:10:04

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Are Zenotech Laboratories Ltd latest results good or bad?

2026-01-23 19:15:32

Zenotech Laboratories Ltd's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a revenue of ₹10.23 crores, reflecting a year-on-year growth of 16.91% and a quarter-on-quarter increase of 18.40%. This revenue growth indicates a positive trend in sales, marking the second-highest quarterly revenue in the company's recent history. However, the net profit for the same quarter was reported at a loss of ₹0.84 crores, which is a significant decline compared to the previous quarter and the same quarter last year. This loss can be attributed to an extraordinary tax charge that exceeded the profit before tax, raising concerns about the company's tax planning and potential prior period adjustments. The effective tax rate for the quarter was an unprecedented 165.87%, which has distorted the profitability metrics and overshadowed the revenue growth. The oper...

Read full news article

Zenotech Laboratories Q2 FY26: Tax Anomaly Triggers Loss Despite Revenue Growth

2026-01-23 18:16:25

Zenotech Laboratories Limited, a micro-cap pharmaceutical company specialising in generic injectables for oncology and anaesthesiology, reported a net loss of ₹0.84 crores in Q2 FY26, a sharp reversal from the ₹0.99 crores profit posted in Q1 FY26. The unexpected loss came despite revenue growth of 18.40% quarter-on-quarter, primarily driven by an extraordinary tax charge of ₹2.09 crores representing a staggering 165.87% tax rate. The stock, currently trading at ₹46.50 with a market capitalisation of ₹276.00 crores, has declined 0.70% over the past week and remains in a bearish technical trend.

Read full news article

Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-01-07 08:16:41

Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators amid ongoing financial headwinds. While the company continues to face significant profitability pressures and valuation concerns, recent technical trend improvements have prompted a more cautious but less negative outlook from analysts.

Read full news article

Zenotech Laboratories Ltd is Rated Strong Sell

2026-01-04 10:10:27

Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 July 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article